Research and Markets (Free subscription) | 10/26/2009
| Acquisition of Huxley Pharmaceuticals Inc by BioMarin Pharmaceutical, Inc - BioMarin Pharmaceutical, Inc. - Earnings Transcript FactSet, Oct 2009 Description Acquisition of Huxley Pharmaceuticals Inc by BioMarin Pharmaceutical, Inc - BioMarin Pharmaceutical, Inc. - Earnings TranscriptMonday, October 26, 2009 09:30
Market Wire (Free subscription) | 08/13/2009
NEW DELHI, INDIA (MARKET WIRE) W.S.S. is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued free ratings reports on the following six companies: CIENA Corp. (NASDAQ: CIEN), Avanir Pharmaceuticals (NASDAQ: AVNR), Digital River Inc. (NASDAQ: DRIV), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Cell Therapeutics...
Miami Herald (Free subscription) | 07/31/2009
BioMarin Pharmaceutical Inc., which develops biopharmaceuticals for diseases, said Thursday it posted a lower second-quarter profit as operating expenses jumped around 32 percent during the period.
Daily Advance - Business (Free subscription) | 07/31/2009
NOVATO, Calif. — BioMarin Pharmaceutical Inc., which develops biopharmaceuticals for diseases,...
San Fransisco Chronicle (Free subscription) | 07/30/2009
BioMarin Pharmaceutical Inc., which develops biopharmaceuticals for diseases, said Thursday it posted a lower second-quarter profit as operating expenses jumped around 32 percent during the period. Profit slid 66 percent to $1.3 million, or a penny per share,... Sponsored Topics: BioMarin Pharmaceutical - Business - Biotechnology and Pharmaceuticals - Biopharmaceutical - Pharmaceuticals
Market Wire (Free subscription) | 07/15/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Umpqua Holdings Corporation (NASDAQ: UMPQ), Lamar Advertising Co. (NASDAQ: LAMR), DryShips Inc. (NASDAQ: DRYS), Tetra Tech...
The San Francisco Business Times (Free subscription) | 06/16/2009
BioMarin Pharmaceutical Inc. said a virus at Genzyme Corp.’s Boston bulk manufacturing plant, which last made BioMarin’s drug Aldurazyme in September, won’t have an impact on the supply of its drug or the Novato company’s revenue. (GENZ) (BMRN)
DeepMarket Stock Market Blog (Free subscription) | 06/10/2009
Seasonal Patterns found for the following stocks: Nvidia Corporation (NVDA) over the next 9 trading days. Look at the seasonal patterns for Nvidia Corporation in context. Biomarin Pharmaceutical Inc. (BMRN) over the next 9 trading days. Look at the seasonal patterns for Biomarin Pharmaceutical Inc. in context. Au Optronics Cp Ads (AUO) over the next 9 [...]
Business Wire (Free subscription) | 06/02/2009
RIVERSIDE, Calif.--(BUSINESS WIRE)--Doe & Ingalls of California announced today that they have been selected by BioMarin Pharmaceutical Inc. to be a key supplier for high purity chemicals used in their commercial
Business Wire (Free subscription) | 05/05/2009
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
The East Bay Business Times (Free subscription) | 04/02/2009
A BioMarin Pharmaceutical Inc. subsidiary is returning its rights to Riquent, a drug that failed to treat a lupus-related condition, to La Jolla Pharmaceutical Co. (BMRN) (LJPC)
Medical News Today (Free subscription) | 03/19/2009
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that its application for clinical trial authorization (CTA) for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome, has been accepted by the United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA). BioMarin...
Red Orbit (Free subscription) | 03/10/2009
NOVATO, Calif., March 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey H.
Darmstadt (Free subscription) | 03/10/2009
Author : BioMarin Pharmaceutical Inc. NOVATO, Calif. , March 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey H. Cooper , Senior ...
Red Orbit (Free subscription) | 03/04/2009
NOVATO, Calif., March 4 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.
Videos